Trough Levels and Antibodies to Infliximab May Not Predict Response to Intensification of Infliximab Therapy in Patients With Inflammatory Bowel Disease
暂无分享,去创建一个
B. Pariente | P. Desreumaux | M. Allez | J. Colombel | D. Émilie | M. Desroches | J. Gornet | R. Krzysiek | C. Baudry | G. P. de Chambrun | Gauthier Louis | C. de Cassan | G. D. de Chambrun